Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma

Journal:

The New England Journal of Medicine

Published:

2025-06-01

DOI:

10.1056/nejmoa2502449

Affiliations:

44

Authors:

46

Go to article

Institutions	Authors	Share
Regeneron Pharmaceuticals, United States of America (USA)	9.000000	0.20
Peter MacCallum Cancer Centre (Peter Mac), Australia	2.000000	0.04
University of Salamanca (USAL), Spain	1.000000	0.02
Gold Coast Health, Australia	1.000000	0.02
H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA)	1.000000	0.02
GenesisCare, Australia	1.000000	0.02
Bendigo Health, Australia	1.000000	0.02
Adelaide Cancer Centre, Australia	1.000000	0.02
Department of Dermatology, Venerology and Allergology, UKSH Kiel, Germany	1.000000	0.02
Hervey Bay Hospital, Australia	1.000000	0.02
Barretos Cancer Hospital, Brazil	1.000000	0.02
University of Planalto Catarinense (UNIPLAC), Brazil	1.000000	0.02
Sir Charles Gairdner Hospital (SCGH), Australia	1.000000	0.02
Townsville University Hospital (TUH), Australia	1.000000	0.02
Ohio State University Wexner Medical Center (OSUWMC), United States of America (USA)	1.000000	0.02
Hospital São Lucas da PUCRS, Brazil	1.000000	0.02
National Cancer Center Hospital, Japan	1.000000	0.02
University Hospital Tübingen (UKT), Uni Tübingen, Germany	1.000000	0.02
Princess Alexandra Hospital, Australia	1.000000	0.02
Andreas Sygros Hospital, Greece	1.000000	0.02
Nebraska Cancer Specialists, United States of America (USA)	1.000000	0.02
State Budgetary Institution of the Krasnodar Region Oncological Dispensary No.2 of MOH of Krasnodar Region, Russia	1.000000	0.02
IRCCS European Institute of Oncology (IEO), Italy	1.000000	0.02
University of Pennsylvania Health System (UPHS), United States of America (USA)	1.000000	0.02
The University of Melbourne (UniMelb), Australia	1.000000	0.02
Bristol Heart Institute (BHI), United Kingdom (UK)	1.000000	0.02
The George Washington University (GW), United States of America (USA)	1.000000	0.02
Royal North Shore Hospital (RNSH), Australia	1.000000	0.02
Calvary Mater Newcastle, Australia	1.000000	0.02
Maria Sklodowska-Curie National Research Institute of Oncology, Poland	1.000000	0.02
Hôpital Saint-Louis, France	1.000000	0.02
IRCCS Humanitas Research Hospital, Italy	0.500000	0.01
Royal Brisbane and Women's Hospital (RBWH), Australia	0.500000	0.01
Centre d’Investigation Clinique 1413 (CIC 1413), France	0.500000	0.01
Immunology and New Concepts in Immunotherapy (INCIT), France	0.500000	0.01
Humanitas University, Italy	0.500000	0.01
The University of Queensland (UQ), Australia	0.500000	0.01
Central Adelaide Local Health Network (CALHN), Australia	0.500000	0.01
Royal Adelaide Hospital (RAH), Australia	0.500000	0.01
Institute Gustave-Roussy (IGR), France	0.500000	0.01
University of Paris-Saclay, France	0.500000	0.01
Wollongong Hospital, Australia	0.500000	0.01
University of Wollongong (UOW), Australia	0.500000	0.01

Interested in Clinical Sciences?